​In December 2022, the United States Congress passed the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act, which made diversity action plans mandatory.  

Carimer is uniquely positioned in an attractive region for conducting multinational, multicenter clinical trials, while also ensuring diversity of trial participants. Our region offers hundreds of clinical sites, all compliant with global industry standards. With a strong operation and practice of having across-the-board Standard Operating Procedures guided by international guidelines, Carimer ensures compliance to the full extent across all operating geographies.